Gaviscon Infant oral powder sachets

Main information

  • Trade name:
  • Gaviscon Infant oral powder sachets
  • Dosage:
  • 225mg ; 87.5mg
  • Pharmaceutical form:
  • Powder
  • Administration route:
  • Oral
  • Class:
  • No Controlled Drug Status
  • Prescription type:
  • Valid as a prescribable product
  • Medicine domain:
  • Humans
  • Medicine type:
  • Allopathic drug

Documents

Localization

  • Available in:
  • Gaviscon Infant oral powder sachets
    United Kingdom
  • Language:
  • English

Therapeutic information

  • Product summary:
  • BNF: 01010200; GTIN: 9300631074038 9300631074038

Status

  • Source:
  • eMC
  • Authorization number:
  • PL 00063/0099
  • Last update:
  • 11-07-2019

Patient Information leaflet: composition, indications, side effects, dosage, interactions, adverse reactions, pregnancy, lactation